TBG Diagnostics Ltd. (ASX:TDL) Share Price, News, Chart & Financials

TBG Diagnostics Ltd.

Level 27, 101 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000

(07) 3273 9133

http://www.tbgbio.com/public/

Sector: Healthcare

Description

TBG Diagnostics Limited (ASX: TDL) develops, manufactures and markets nucleic acid test kits and offers related services. The Company serves the molecular diagnostic industry around the world. The company is headed by Mr. Jitto Arulampalam, who is also an Executive Chairman of the company. The company’s Registered and Principal Office is situated in Melbourne, Australia. The company came into existence in the Year 1999.

Peers

SUD

Suda Pharmaceuticals Ltd.

NOX

Noxopharm Limited

NVAX

Novavax Inc

ANP

Antisense Therapeutics Ltd.

BPH

BPH Energy Limited

CHM

Chimeric Therapeutics Limited

CYP

Cynata Therapeutics Limited

NYR

Nyrada Inc.

PFE

Pfizer Inc

MRNA

Moderna Inc

IMU

Imugene Limited

RAD

Radiopharm Theranostics Limited

Close

TBG Diagnostics Ltd.

TBG Diagnostics Ltd.

Description

Peers

SUD

NOX

NVAX

ANP

BPH

CHM

CYP

NYR

PFE

MRNA

IMU

RAD

Sponsored Articles

Related Articles